Accueil>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>E3 ligase Ligand-Linker Conjugates 7 Free Base

E3 ligase Ligand-Linker Conjugates 7 Free Base (Synonyms: VH032-PEG4-NH2; VHL Ligand-Linker Conjugates 4 ; E3 ligase Ligand-Linker Conjugates 7 Free Base)

Catalog No.GC32994

E3 ligase Ligand-Linker Conjugates 7 Free Base est un conjugué ligand-linker E3 synthétisé qui incorpore le ligand VHL basé sur (S,R,S)-AHPC et le linker PEG À 4 unités utilisé dans la technologie PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

E3 ligase Ligand-Linker Conjugates 7 Free Base Chemical Structure

Cas No.: 2010159-57-4

Taille Prix Stock Qté
10mM (in 1mL DMSO)
308,00 $US
En stock
100mg
280,00 $US
En stock
500mg
1 080,00 $US
En stock
1g
1 980,00 $US
En stock
2g
2 800,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

E3 ligase Ligand-Linker Conjugates 7 Free Base is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology.

E3 ligase Ligand-Linker Conjugates 7 Free Base, extracted from patent US20170008904A1, can be used in the synthesis of compound A1895 in example 3[1].

[1]. Crew, Andrew P, et al. MDM2-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE. US20170008904A1.

Avis

Review for E3 ligase Ligand-Linker Conjugates 7 Free Base

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for E3 ligase Ligand-Linker Conjugates 7 Free Base

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.